Vitamin K2  100mcg  30 caps Maximize

Vitamin K2 mk7 100mcg 50 caps

Vitamin K2  mk7    100mcg  50 caps

More details

BRL 233.71

On sale On sale!

By buying this product you can collect up to 11 loyalty points. Your cart will total 11 points that can be converted into a voucher of BRL 2.20.

Vitamin K2   mk7   


50 caps

Brazilian researchers discovered a new substance which attacks cancer cells and tumores.


althought the effect is proven in more than 900 patients which this researcher supplies with samples, the official opinion is logically against. Can´t be what must not be.

Blocking clinical tests and licensing of natural products is normal for Pharmaindustry.


other researchers discovered that this FOSFOETANOLAMINA is produced in our body, but too less to be effective, but by taking


the production increases 500% and becomes active against cancer cells and tumores.

Package with 50 caps 100mcg each

1 daily


1. Mizuta T, Ozaki I. Clinical application of vitamin K for hepatocellular carcinoma. Clin Calcium. 2007 Nov;17(11):1693-9.
2. Otsuka M, Kato N, Shao RX, et al. Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology. 2004 Jul;40(1):243-51.
3. Nishikawa Y, Wang Z, Kerns J, Wilcox CS, Carr BI. Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition. J Biol Chem. 1999 Dec 3;274(49):34803-10.
4. Yamamoto T, Nakamura H, Liu W, et al. Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2). J Gastroenterol. 2009;44(3):228-35.
5. Kuriyama S, Hitomi M, Yoshiji H, et al. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol. 2005 Aug;27(2):505-11.
6. Matsumoto K, Okano J, Nagahara T, Murawaki Y. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol. 2006 Dec;29(6):1501-8.
7. Kim HJ, Mun JY, Chun YJ, Choi KH, Ham SW, Kim MY. Effects of a naphthoquinone analog on tumor growth and apoptosis induction. Arch Pharm Res. 2003 May;26(5):405-10.
8. Sakai I, Hashimoto S, Yoda M, et al. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines. Biochem Biophys Res Commun. 1994 Dec 15;205(2):1305-10.
9. Sun L, Yoshii Y, Miyagi K, Ishida A. Proliferation inhibition of glioma cells by vitamin K2. No Shinkei Geka. 1999 Feb;27(2):119-25.
10. Tokita H, Tsuchida A, Miyazawa K, et al. Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines. Int J Mol Med. 2006 Feb;17(2):235-43.
11. Ogawa M, Nakai S, Deguchi A, et al. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol. 2007 Aug;31(2):323-31.
12. Taper HS, Jamison JM, Gilloteaux J, Gwin CA, Gordon T, Summers JL. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K(3) combination. J Histochem Cytochem. 2001 Jan;49(1):109-20.
13. Yoshida T, Miyazawa K, Kasuga I, et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003 Sep;23(3):627-32.
14. Yokoyama T, Miyazawa K, Yoshida T, Ohyashiki K. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines. Int J Oncol. 2005 Jan;26(1):33-40.
15. Kassouf W, Highshaw R, Nelkin GM, Dinney CP, Kamat AM. Vitamins C and K3 sensitize human urothelial tumors to gemcitabine. J Urol. 2006 Oct;176(4 Pt 1):1642-7.
16. Wei G, Wang M, Hyslop T, Wang Z, Carr BI. Vitamin K enhancement of Sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Int J Cancer. 2010 Jun 7.
17. Scott GK, Atsriku C, Kaminker P, et al. Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. Mol Pharmacol. 2005 Sep;68(3):606-15.
18. Verrax J, Taper H, Buc Calderon P. Targeting cancer cells by an oxidant-based therapy. Curr Mol Pharmacol. 2008 Jan;1(1):80-92.
19. Enomoto M, Tsuchida A, Miyazawa K, et al. Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines. Int J Mol Med. 2007 Dec;20(6):801-8.
20. Yokoyama T, Miyazawa K, Naito M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy. 2008 Jul 1;4(5):629-40.
21. Verrax J, Cadrobbi J, Delvaux M, et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem. 2003 May;38(5):451-7.
22. Nouso K, Uematsu S, Shiraga K, et al. Regression of hepatocellular carcinoma during vitamin K administration. World J Gastroenterol. 2005 Nov 14;11(42):6722-4.

No customer comments for the moment.